Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 3.72B | 4.9% |
| Gross Profit | 3.01B | 7.8% |
| Cost of Revenue | 714M | 5.9% |
| Operating expense | 1.99B | 1.4% |
| Net Income | 1.34B | 6.4% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 37.4B | 3.8% |
| Total Liabilities | 8.12B | 3% |
| Total Equity | 29.3B | 4% |
| Shares Outstanding | 108M | 0% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | 1.29B | 264.7% |
| Cash from investing | -574M | 3.1% |
| Cash from financing | -634M | 32.6% |
EPS
Financial Highlights for Regeneron in Q3 '24
Regeneron reported a revenue of 3.72B, which is a 4.9% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 3.01B, marking a 7.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 714M, a -5.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 1.99B, showing a 1.4% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.34B, showing a -6.4% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Regeneron faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
